検索結果

Publications | Research & Development | SENJU Pharmaceutica

1 Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, 2 Senju Laboratory of Ocular Science, Senju Pharmaceutical Co., Ltd., Kobe Investigative Ophthalmology &...

R&D Pipeline | Research & Development | SENJU Pharmaceutica

PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia) Pranoprofeninflammati

MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical

Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r

類の胎児・新生児の鎮痛・麻酔および安楽死に関する声明（平成 27 年 11 月 11 日 第 2 版、日本実験動物医学会） 10) The Guide for the Care and Use of LaboratoryAnimals 8th edition. National Research Council, 2011. 11) AVMA Guidelines for the Euthanas...

Meetings of the Minds | Research & Development | SENJU Pharmaceutica

1 Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, 2 Senju Laboratory of Ocular Science, Senju Pharmaceutical Co., Ltd., Kobe ARVO 2019 開催日：2019年4月27日～5月2日 開催地...